Wall Street Analysts Predict a 27.12% Upside in Amneal (AMRX): Here's What You Should Know

Amneal Pharmaceuticals (AMRX) closed the last trading session at $8.26, gaining 5.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $10.50 indicates a 27.1% upside potential.The average comprises four short-term price targets ranging from a low of $9 to a high of $12, with a standard deviation of $1.29. While the lowest estimate indicates an increase of 9% from the current price l ...